Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,458 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era.
Catania C, Piperno G, Russo A, Greco C, Agustoni F, Scotti V, Proto C, Sangalli C, Patani F, Santacaterina A, Di Pietro Paolo M, Agresti B, Filippi AR, Ramella S. Catania C, et al. Among authors: russo a. Crit Rev Oncol Hematol. 2022 Jun;174:103684. doi: 10.1016/j.critrevonc.2022.103684. Epub 2022 Apr 21. Crit Rev Oncol Hematol. 2022. PMID: 35462031 Review.
NSCLC and HER2: between lights and shadows.
Ricciardi GR, Russo A, Franchina T, Ferraro G, Zanghì M, Picone A, Scimone A, Adamo V. Ricciardi GR, et al. Among authors: russo a. J Thorac Oncol. 2014 Dec;9(12):1750-62. doi: 10.1097/JTO.0000000000000379. J Thorac Oncol. 2014. PMID: 25247338 Free article. Review.
Targeted Therapies in Early Stage NSCLC: Hype or Hope?
Friedlaender A, Addeo A, Russo A, Gregorc V, Cortinovis D, Rolfo CD. Friedlaender A, et al. Among authors: russo a. Int J Mol Sci. 2020 Aug 31;21(17):6329. doi: 10.3390/ijms21176329. Int J Mol Sci. 2020. PMID: 32878298 Free PMC article. Review.
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients.
Malapelle U, Rossi G, Pisapia P, Barberis M, Buttitta F, Castiglione F, Cecere FL, Grimaldi AM, Iaccarino A, Marchetti A, Massi D, Medicina D, Mele F, Minari R, Orlando E, Pagni F, Palmieri G, Righi L, Russo A, Tommasi S, Vermi W, Troncone G. Malapelle U, et al. Among authors: russo a. Crit Rev Oncol Hematol. 2020 Dec;156:103118. doi: 10.1016/j.critrevonc.2020.103118. Epub 2020 Oct 3. Crit Rev Oncol Hematol. 2020. PMID: 33038627 Review.
Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021.
Pisapia P, Costa JL, Pepe F, Russo G, Gragnano G, Russo A, Iaccarino A, de Miguel-Perez D, Serrano MJ, Denninghoff V, Quagliata L, Rolfo C, Malapelle U. Pisapia P, et al. Among authors: russo g, russo a. Crit Rev Oncol Hematol. 2021 May;161:103311. doi: 10.1016/j.critrevonc.2021.103311. Epub 2021 Mar 26. Crit Rev Oncol Hematol. 2021. PMID: 33781866 Review.
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.
Cortellini A, Giusti R, Filetti M, Citarella F, Adamo V, Santini D, Buti S, Nigro O, Cantini L, Di Maio M, Aerts JGJV, Bria E, Bertolini F, Ferrara MG, Ghidini M, Grossi F, Guida A, Berardi R, Morabito A, Genova C, Mazzoni F, Antonuzzo L, Gelibter A, Marchetti P, Chiari R, Macerelli M, Rastelli F, Della Gravara L, Gori S, Tuzi A, De Tursi M, Di Marino P, Mansueto G, Pecci F, Zoratto F, Ricciardi S, Migliorino MR, Passiglia F, Metro G, Spinelli GP, Banna GL, Friedlaender A, Addeo A, Ficorella C, Porzio G, Tiseo M, Russano M, Russo A, Pinato DJ. Cortellini A, et al. Among authors: russo a. J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2. J Hematol Oncol. 2022. PMID: 35062993 Free PMC article.
The evolving landscape of anatomic pathology.
Pisapia P, L'Imperio V, Galuppini F, Sajjadi E, Russo A, Cerbelli B, Fraggetta F, d'Amati G, Troncone G, Fassan M, Fusco N, Pagni F, Malapelle U. Pisapia P, et al. Among authors: russo a. Crit Rev Oncol Hematol. 2022 Oct;178:103776. doi: 10.1016/j.critrevonc.2022.103776. Epub 2022 Aug 5. Crit Rev Oncol Hematol. 2022. PMID: 35934262 Review.
Stereotactic boost on residual disease after external-beam irradiation in clinical stage III non-small cell lung cancer: mature results of stereotactic body radiation therapy post radiation therapy (SBRTpostRT) study.
Parisi S, Ferini G, Lillo S, Brogna A, Chillari F, Ferrantelli G, Settineri N, Santacaterina A, Platania A, Leotta S, Casablanca G, Russo A, Pontoriero A, Adamo V, Minutoli F, Bottari A, Cacciola A, Pergolizzi S. Parisi S, et al. Among authors: russo a. Radiol Med. 2023 Jul;128(7):877-885. doi: 10.1007/s11547-023-01659-w. Epub 2023 Jun 9. Radiol Med. 2023. PMID: 37294366
4,458 results